Detalles de la búsqueda
1.
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
Bioorg Med Chem Lett;
27(20): 4606-4613, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939121
2.
Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.
Cancers (Basel);
15(6)2023 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980623
3.
The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.
Blood Cancer J;
12(4): 57, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35410412
4.
Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
Oncotarget;
8(68): 112610-112622, 2017 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29348850
Resultados
1 -
4
de 4
1
Próxima >
>>